Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts

University Hospital, Brest15 enrolled

Overview

Assessment of the feasibility of a monitoring device by SMS in which messages are sent by the caregiver after a suicidal act.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Prevention of the Suicide

Interventions

SMSDEVICE

SMS contact from the caregiver with patient after discharge in intervention group

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female, over 18 years of age and hospitalized; * Survivor of a suicide attempt; * Giving informed, dated and signed consent; * Can be reached by mobile phone. The study is proposed to all adult suicides and to the patient's designated caregiver, meeting the inclusion criteria. Exclusion Criteria: * Patient whose clinical condition is incompatible with the formulation of his non-opposition. * The patient and his / her caregiver shall not be afforded a protective justice measure.

Locations (1)

CHU de Brest

Brest, France

Outcomes

Primary Outcomes

Measurement of the feasibility of the device by the patient according to a validated questionnaire

The primary endpoint is the measurement of the feasibility of the device by the patient based on a validated questionnaire. This evaluation will take place during the medical interview that will close the study participation.

Time frame: 6 months

Secondary Outcomes

The questionnaire measuring the feasibility for the caregiver of such a device

A questionnaire will be provided to the caregiver to measure the feasibility of such a device

Time frame: 6 months

Questionnaires on the acceptability of patients and caregivers in relation to the use of this type of monitoring device

Acceptability questionnaires will be provided to patients and caregivers in relation to the use of this type of monitoring device

Time frame: 6 months

Qualitative analysis of messages sent to patients during the study.

A qualitative analysis of the messages addressed to the patients during the study will be carried out.

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.